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Antigen-Specific T Cell Sensitization Is Impaired
in IL-17-Deficient Mice, Causing Suppression
of Allergic Cellular and Humoral Responses
17; their identity with IL-17 is 16%–50% (Aggarwal and
Gurney, 2002). A receptor for IL-17 (IL-17R) has been
identified and found to share no homology with any
other cytokine receptor family. Its mRNA expression
shows a ubiquitous tissue distribution (Yao et al., 1995a).
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IL-17 has pleiotropic activities including induction of
TNF-, IL-1, IL-6, IL-8, G-CSF, and MCP-1 on variousInterleukin-17 (IL-17) is a proinflammatory cytokine
types of cells (Fossiez et al., 1998; Jovanovic et al.,produced by T cells. The involvement of IL-17 in human
1998), upregulation of ICAM-1 and HLA-DR expressiondiseases has been suspected because of its detection
on kerationocytes (Albanesi et al., 1999), induction ofin sera from asthmatic patients and synovial fluids
iNOS and cyclooxygenase-2 (cox-2) on chondrocytesfrom arthritic patients. In this study, we generated IL-
(Shalom-Barak et al., 1998), induction of cox-2-depen-17-deficient mice and investigated the role of IL-17 in
dent PGE2-mediated osteoclast differentiation factorvarious disease models. We found that contact, de-
(ODF) expression on osteoblasts (Kotake et al., 1999),layed-type, and airway hypersensitivity responses, as
and promotion of SCF- and G-CSF-mediated granulo-well as T-dependent antibody production, were signifi-
poiesis (Schwarzenberger et al., 2000). IL-17 acts oncantly reduced in the mutant mice, while IL-17 defi-
T cells as a costimulatory factor (Yao et al., 1995a),ciency of donor T cells did not affect acute graft-ver-
enhances allorejection via promotion of dendritic cellsus-host reaction. The results suggest that impaired
(DC) maturation (Antonysamy et al., 1999), and promotesresponses were caused by the defects of allergen-
tumor rejection by activation of NK cells (Hirahara et al.,specific T cell activation. Our findings indicate that
2000). IL-17 has also been detected in the sera as wellIL-17 plays an important role in activating T cells in
as the diseased organs and tissues of various patients,
allergen-specific T cell-mediated immune responses.
suggesting its involvement in the development of vari-
ous human diseases such as rheumatoid and Lyme ar-
Introduction thritis and osteoarthritis (Attur et al., 1997; Aarvak et
al., 1999; Infante-Duarte et al., 2000), multiple sclerosis
IL-17 is a T cell-derived proinflammatory cytokine origi- (Matusevicius et al., 1999), systemic lupus erythemato-
nally named cytotoxic T lymphocyte-associated serine sus (Wong et al., 2000), allograft rejection (Antonysamy
esterase-8 (CTLA-8) (Rouvier et al., 1993). Murine IL-17 et al., 1999), and asthma (Wong et al., 2001). Further-
is a 21 kDa glycoprotein, consisting of 147 amino acids, more, IL-17 has been shown to be involved in the host
which has a 63% amino acid homology with human IL- defense mechanism against Klebsiella pneumoniae in-
17 (155 amino acids) (Yao et al., 1995b). It has no obvious fection by using IL-17R/ mice (Ye et al., 2001). Neither
homology with other cytokines but has a 57% homology the exact pathophysiologic role of IL-17 nor its mecha-
with the predicted amino acid sequence of the open nisms of action in the immune system, however, have
reading frame 13 (ORF13) of Herpesvirus saimiri (HVS) been completely elucidated.
(also called vIL-17) (Rouvier et al., 1993). In this study, we generated IL-17-deficient (IL-17/)
Recently, human IL-17 has been found to be included mice in order to elucidate the roles of IL-17 in various
in a novel cytokine family consisting of IL-17B, IL-17C, inflammatory diseases and immune responses. Using
IL-17D, IL-17E, and IL-17F in addition to IL-17 and vIL- this model, we have shown that IL-17 is involved in
diseases such as contact hypersensitivity (CHS), de-
layed-type hypersensitivity (DTH), and airway hypersen-5 Correspondence: iwakura@ims.u-tokyo.ac.jp
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Figure 1. Generation of IL-17/ Mice
(A) Structure of the mouse il-17 locus (Wild-
type allele), the IL-17 targeting construct (Tar-
geting construct), and the predicted mutated
il-17 gene before (Targeting allele) and after
neomycin resistance gene (neor) deletion
(After Cre-mediated neor deletion). Exons are
represented by boxes. Exon 1 and 2 of the
il-17 gene were replaced with the EGFP gene
and the neor gene flanked by lox P se-
quences. A DT gene was attached to the 5
end of the genomic fragment for negative se-
lection. The external homologous regions
shown in the targeting allele were used as
the genomic probe for Southern blot analysis.
Southern blot analysis for targeted clone
screening was carried out using XbaI (X).
Primers 1, 2, and 3 were used for genotyping
of mice.
(B) Southern blot analysis of the thymus DNA
from IL-17 wild-type (/), heterozygous
(/), and mutant (/) littermates. The en-
dogenous (10 kb) and targeted (3.5 kb) bands
were shown using the 5 probe.
(C) Northern blot analysis of the IL-17 mRNA
from splenic T cells stimulated with plate-
coated anti-CD3 plus anti-CD28 mAb for
48 hr.
sitivity response (AHR), but not in acute graft-versus- and spleen among IL-17/, IL-17/, and IL-17/ mice
(data not shown).host reaction (GVHR), through activation of T cell
priming.
T Cell Response to Mitogenic Stimuli
IL-17 is known as a T cell costimulatory factor (Yao etResults
al., 1995a). To examine whether IL-17 is necessary for
T cell activation, splenic T cells from IL-17/ mice wereGeneration of IL-17-Deficient Mice
We generated IL-17/ mice by replacing the exon 1 stimulated with plate-coated anti-CD3 plus anti-CD28
mAb. Proliferative responses of IL-17/ T cells and IL-4and 2 of the il-17 gene with a neomycin resistance gene
(Figure 1A). Correct targeting of the IL-17 locus was and IFN- production were normal (Figures 2A and 2B),
although IL-17 production was completely abolishedconfirmed by genomic Southern blot analysis (Figure
1B). The expression of IL-17 mRNA was not detected (Figure 2C). Proliferative responses of whole spleen cells
to other mitogenic stimuli such as ConA, PHA, and PMAby Northern blot analysis in splenic T cells from IL-17/
mice stimulated with plate-coated anti-CD3 plus anti- plus ionomycin were also shown to be normal in IL-
17/ mice (Figure 2D). Therefore, these results indicateCD28 mAb (Figure 1C). The levels of IL-17 protein in the
supernatant from IL-17/ T cell cultures were below that IL-17 is not necessary for either cell proliferation
or IL-4 or IFN- production by T cells in response tothe limit of detection by ELISA (Figure 2C).
IL-17/ mice were generated from the cross between nonspecific mitogenic stimuli.
IL-17/ mice at the expected Mendelian ratio. They
were fertile and did not show any gross phenotypic CHS
It was shown that nickel-specific skin-derived T cellsabnormalities under specific pathogen-free housing
conditions (data not shown). No apparent abnormalities produce IL-17, and this IL-17 induces IL-6 and IL-8 pro-
duction as well as ICAM-1 and HLA-DR expression onwere found in the cell populations of the thymus, LNs,
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Figure 2. T Cell Functions of IL-17/ Mice
Splenic T cells (A, B, and C) and whole spleen
cells (D) from IL-17/, IL-17/, and IL-17/
mice were stimulated with mitogenic stimuli.
Proliferative responses (A), IL-4 and IFN-
levels (B), and IL-17 levels (C) in the culture
supernatants are shown after stimulation with
plate-coated anti-CD3 plus anti-CD28 mAb
for 48 hr, and proliferative responses to mito-
gens after 48 hr are shown in (D). Average 
SD of three wells is shown in the proliferation
assay, and cytokine levels in pooled superna-
tant from three wells were determined by
ELISA. These results were reproducible in
two independent experiments.
keratinocytes in humans (Albanesi et al., 1999). To eluci- IL-17/ mice were cocultured with CD11c DCs from
IL-17/ or IL-17/ mice in the absence or presence ofdate the role of IL-17 in hapten-specific skin diseases,
we investigated CHS responses in IL-17/ mice. DNFB- DNBS, IL-17/ DCs could promote T cell proliferation
in a manner similar to IL-17/ DCs (Figure 3E). Further-and TNCB-induced CHS responses in IL-17/ mice
were markedly suppressed compared with those in IL- more, when nontreated IL-17/ mice were injected with
TNP-conjugated splenic DCs from IL-17/ or IL-17/17/ mice (Figures 3A and 3B). The response in IL-
17/ mice was similar to that in IL-17/ mice (data not mice, the severity of CHS in mice that received IL-17/
DCs was similar to that in IL-17/ mice that receivedshown). IL-17/ mice exhibited infiltration of a large
number of inflammatory cells into the TNCB-challenged IL-17/ DCs (Figure 3F). Thus, these results indicate
that IL-17 deficiency does not affect LC/DC functionear epidermis, while cell infiltration was not shown in
vehicle-treated ears (Figure 3C). In contrast, inflamma- during CHS response. On the other hand, TNP- and
DNP-specific T cell proliferative responses from drainingtory cell infiltration in TNCB-treated ears was markedly
reduced in IL-17/ mice (Figure 3C). LNs of IL-17/ mice were significantly decreased com-
pared with those of IL-17/ mice (Figures 3G and 3H).IL-17 is known to enhance T cell activation via promo-
tion of DC maturation (Antonysamy et al., 1999). Langer- Among CD3 cells, CD4 T cells but not CD8 T cells
showed reduced proliferative response against DNBShans cells (LCs), which are the major antigen-presenting
cells in CHS response, are immature in the skin and (Figure 3I). IFN- production after stimulation with DNBS
was markedly reduced in the IL-17/ T cell culture,maturate during the migration process from the skin to
draining LNs after activation with antigens (Grabbe and while IL-4 production was almost undetectable both in
the IL-17/ T cell and the IL-17/ T cell cultures (FigureSchwarz, 1998). However, LC migrating into draining
LNs from the skin expressed normally cell surface acti- 3H). When TNCB-sensitized T cells were transferred into
nontreated mice, the CHS response in mice that re-vation markers, CD40 and CD86, in IL-17/ mice after
painting with FITC on the skin (Figure 3D). Six hours ceived T cells from IL-17/ mice was significantly lower
compared with the response in mice that received Tafter LPS stimulation, IL-12 expression in FITCCD11c
LCs was also comparable between IL-17/ and IL-17/ cells from IL-17/ mice (Figure 3J). However, when IL-
17/ mice were previously transplanted with CD4 Tmice (Figure 3D). When T cells from DNFB-sensitized
Immunity
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cells from wild-type mice before sensitization, CHS in ment of IL-17 in this process, consistent with the results
of a previous report (Fossiez et al., 1998) and with thethese reconstituted mice was recovered to the levels
of wild-type mice (Figure 3K). Therefore, these results finding that the expression of chemokine mRNAs for
Gro, MIP-1, and MIP-2 were found to be reduced (Fig-indicate that IL-17 is required for hapten-specific T cell
activation, especially for CD4 T cells, but not for LC ure 4E). These results show that IL-17 also plays an
important role in the infiltration process of inflammatorymaturation in the sensitization phase of CHS response.
To elucidate the effects of IL-17 deficiency on humoral cells.
It is known that TNF- is also involved in CHS re-immunity, TNP-specific Ig levels in sera from IL-17/
mice at 3 days after TNCB challenge were determined sponse, and it was reported recently that IL-17 was
expressed by T cells producing TNF- (Infante-Duarteby ELISA. All TNP-specific IgG subclass levels in sera
from IL-17/ mice were significantly lower compared et al., 2000). We then examined whether or not the role
of IL-17 in CHS response was different from that ofwith those from IL-17/ mice (Figure 4A). Thus, we
showed that IL-17 also plays an important role in hu- TNF-. TNF- production in the inflammatory sites was
normal in IL-17/ mice, and IL-17 production on T cellsmoral immunity.
In the elicitation phase of CHS, various cells such as of TNF-/ mice was also found to be normal (data not
shown). CHS responses in TNF-/ mice as well as inneutrophils, macrophages, and T cells were seen to have
infiltrated the sites which were chemically challenged. In IL-17/ mice were similarly reduced compared with
those in wild-type mice, and those in IL-17/ x TNF-this phase, vascular permeability is important for cellular
infiltration. Because of this, we investigated the vascular / mice were severely reduced compared with those
in TNF-/ or in IL-17/ mice (Figure 4G).permeability of IL-17/ mice, since IL-17 is thought to
be involved in this process through the induction of These results suggest that the reduced CHS response
in IL-17/ mice is caused by a TNF--independentiNOS and cox-2 (Shalom-Barak et al., 1998). One hour
after a TNCB challenge, exudation of Evans blue dye in mechanism. Taken together, these results indicate that
IL-17 has an important role in hapten-specific cellularthe ear was normal in IL-17/ mice (Figure 4B).
To assess the effect of IL-17 deficiency on the expres- and humoral immunities during CHS response.
sion of proinflammatory cytokines, chemokines, and cell
adhesion molecules, protein and mRNA levels were ana- DTH
We examined the role of IL-17 in the DTH response,lyzed by ELISA and Northern blot hybridization analysis,
respectively. IL-1, IL-1, and TNF- levels in the lysate which is a Th1 cell-mediated cellular immune response.
Methylated-BSA (mBSA)-induced DTH response in IL-of the IL-17/ mouse ears challenged with TNCB were
similar to those of IL-17/ mice. In addition, these cyto- 17/ mice was suppressed to approximately 80% of
the average response in IL-17/ mice (Figure 5A). In IL-kines were produced with similar kinetics (Figures 4C
and 4D), although IL-17 was not produced in IL-17/ 17/ mice, cell infiltration at the inflammatory site was
milder than in IL-17/ mice (data not shown). The T cellmice (Figure 4C). On the other hand, the mRNA levels
of chemokines were reduced by 20%–50% in IL-17/ proliferative response of IL-17/ mice against mBSA
was reduced compared with those of IL-17/ mice (Fig-mice compared with IL-17/ mice at 6 hr after TNCB
challenge (Figure 4E). ICAM-1 expression also de- ure 5B). Consistent with the proliferation levels, IFN-
production in culture supernatants from IL-17/ micecreased partially in IL-17/ mice (Figure 4E).
The level of neutrophil infiltration was estimated by was also found to be lower than that from IL-17/ mice
(Figure 5C). IL-4 levels were below the level of detectionMPO assay (Figure 4F). The results showed the involve-
Figure 3. Impaired CHS Response in IL-17/ Mice
(A) Increase of ear swelling in DNFB-induced CHS 24 hr after the second challenge.
(B) Increase of ear swelling in TNCB-induced CHS 24 hr after the second challenge.
(C) Histology of the ear skin at 24 hr after the challenge with TNCB or vehicle alone. Hematoxylin-eosin staining, 40.
(D) CD40, CD86, and IL-12 expression on CD11c FITC LCs. The expression of activation marker on LCs migrating into draining LNs from
the skin 24 hr after FITC painting was analyzed by FACS. For IL-12 expression, draining LNs from the skin 24 hr after painting with FITC were
stimulated with 10 	g/ml LPS plus 2 	M monensin for 6 hr. Shaded area shows an isotype-matched control Ig staining.
(E) Antigen presentation ability of IL-17/ DCs. DNFB-sensitized IL-17/ T cells (5  105 cells) were cocultured with DCs from IL-17/ or
IL-17/ mice in the absence or presence of 25 	g/ml DNBS for 3 days, and then [3 H] TdR incorporation was measured.
(F) CHS response after adoptive transfer of DCs. CD11c splenic DCs were purified from IL-17/ or IL-17/ mice and treated with TNBS.
Then, the TNP-conjugated DCs were transferred into IL-17/ recipient mice, and CHS was measured after challenging with TNCB.
(G) Reduced TNP-specific T cell proliferation response in IL-17/ mice. Inguinal and axillary LN T cells were purified from IL-17/ or IL-17/
mice sensitized with TNCB 5 days after the first challenge and were cocultured with TNBS-treated splenic adherent cells for 3 days.
(H) DNP-specific T cell proliferative responses and IL-4 and IFN- production. Inguinal and axillary LN cells from IL-17/ or IL-17/ mice
sensitized with DNFB were harvested 5 days after the first challenge and cultured in the absence or presence of 50 	g/ml DNBS for 3 days.
(I) Inguinal and axillary LN CD4 or CD8 cells from IL-17/ or IL-17/ mice sensitized with DNFB were cocultured with splenic adherent
cells in the absence or presence of 50 	g/ml DNBS for 3 days.
(J) CHS response after adoptive transfer of T cells. Inguinal and axillary LN T cells from TNCB-sensitized IL-17/ or IL-17/ mice were
transferred, and CHS response of the T cell-transferred mice was examined by challenging TNCB on the ear.
(K) Reconstitution of IL-17/ mice with IL-17/ CD4 T cells. CD4 T cells (4  107 cells) were purified from IL-17/ mice, and they were
injected into naive IL-17/ or IL-17/ mice. Then, these mice were sensitized with TNCB, and CHS was measured.
(A, B, F, J, and K) Each circle represents an individual mouse, and average and SD are shown. (E, G, H, and I) Average  SD of three wells
is shown in the proliferation assay, and cytokine levels in a pooled supernatant from three wells from proliferative response assay were
determined by ELISA. These results were reproducible in at least three independent experiments.
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Figure 4. Impaired CHS Response in IL-17/ Mice
(A) TNP-specific antibody production during CHS response. Three days after the challenge with TNCB, sera were collected and antibody
levels were measured by ELISA.
(B) Vascular permeability in CHS response. Evans blue dye was injected intravenously after the challenge with TNCB, and 1 hr later, exudative
dye in the ear skin was extracted, and the absorbancy at 650 nm was measured.
(C) IL-1, IL-1, TNF-, and IL-17 levels in the ear after challenge with TNCB. The ears were removed at the time indicated after the second
challenge, and cytokine levels in the lysate were measured by ELISA. The average of three mice is shown.
(D) IL-1, IL-1, and TNF- levels in the lysate of the ear challenged with TNCB. Cytokine levels were measured by ELISA 24 hr after the
challenge.
(E) Northern blot analysis of the mRNAs of chemokines and an adhesion molecule in the ear skin at 6 hr after the challenge with TNCB. -actin
mRNA was used to normalize the amount of loaded RNA, and the relative values in IL-17/ mice compared to those in IL-17/ mice are shown.
(F) MPO activity in CHS response. The lysate of the ear skin was prepared at 24 hr after the challenge with TNCB, and MPO activity was measured.
(G) TNCB-induced CHS responses in IL-17/, TNF-/, and IL-17/ x TNF- / mice.
(A, B, D, F, and G) Each circle represents an individual mouse, and average and SD are shown. p 
 0.05; **, p 
 0.01; #, p 
 0.005.
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Figure 5. Impaired DTH Response in IL-17/
Mice
(A) Increase of footpad thickness in mBSA-
induced DTH response. Each circle repre-
sents an individual mouse, and average and
SD are shown.
(B) mBSA-specific T cell proliferative re-
sponse. Inguinal LN cells from IL-17/ or
IL-17/ mice sensitized with mBSA/CFA
subcutaneously for 1 week were cultured in
the absence or presence of 40 	g/ml mBSA
for 3 days. The average  SD of three wells
is shown. These results were reproducible in
three independent experiments.
(C) IL-4 and IFN- levels in the pooled super-
natant of three wells from proliferative re-
sponse assay were determined by ELISA.
These results were reproducible in three inde-
pendent experiments.
(D) mBSA-specific antibody levels after DTH
reaction. One week after the challenge with
mBSA, sera were collected, and mBSA-spe-
cific antibody levels were measured. Each
circle represents an individual mouse, and
average and SD are shown.
in both IL-17/ and IL-17/ culture supernatants (Fig- IL-17/, IL-17/, and IL-17/ mice. Moreover, IL-4 and
IL-5 levels in the BALF from IL-17/ mice at 24 hr afterure 5C). One week after the DTH response, mBSA-spe-
cific IgG1 and IgG3 levels in sera from IL-17/ mice the last inhalation with OVA were higher than those from
IL-17/ and IL-17/ mice (data not shown). The appar-were significantly reduced compared with those in IL-
17/ mice (Figure 5D). These results indicate that IL- ent discrepancy between the reduced T cell activation
and normal AHR with pulmonary inflammation in IL-17 also plays an important role in the induction of the
Th1-mediated DTH response. 17/mice may be explained by the effect of alum, which
induces an excess Th2 response independently from
IL-4 and IL-13 signaling (Brewer et al., 1999).AHR
We then examined the role of IL-17 in OVA-inducedIL-17 is found in the sera of allergic asthma patients
AHR without alum using IL-17/ x DO11.10 transgenic(Wong et al., 2001). In order to assess whether or not
(Tg) mice. Twenty-four hours after the last inhalation withIL-17 is involved in the development of asthma, we ana-
OVA, the AHR to methacholine in IL-17/ x DO11.10 Tglyzed OVA/alum-induced AHR using IL-17/ mice. Five
mice was partially decreased compared with that in IL-days after the first immunization with OVA/alum intra-
17/ x DO11.10 Tg mice (Figure 6F). Consistent withperitoneally, the proliferative response of the mesenteric
AHR, the number of total infiltrated cells in BALF fromLN cells from IL-17/ mice against OVA was markedly
IL-17/ x DO11.10 Tg mice was reduced comparedreduced compared with that of the IL-17/ mice (Figure
with that of IL-17/ x DO11.10 Tg mice (Figure 6G).6A). IL-4 and IL-5 levels in the supernatant of IL-17/
As expected, pulmonary inflammation in IL-17/ xLN cell cultures were also lower than those of IL-17/
DO11.10 Tg mice was also found to be milder than thatLN cell cultures, while IFN- levels of both IL-17/ and
of IL-17/ x DO11.10 Tg mice (Figure 6H). These obser-IL-17/ LN cell cultures were similar (Figure 6B).
vations indicate that IL-17 is involved in the inductionFurthermore, when mice were immunized with OVA/
of AHR.alum intraperitoneally, OVA-specific IgG1 and IgE levels
in IL-17/ mice were significantly reduced compared
with those in IL-17/ mice (Figure 6C). In spite of the Acute GVHR
We then examined the role of IL-17 in acute GVHR.reduced OVA-specific T cell responses, the AHR to
methacholine in IL-17/ mice were similar to those of When splenocytes from IL-17/ or IL-17/ mice on
the C57BL/6J background (H-2Kb) were transferred intoIL-17/ and IL-17/ mice (Figure 6D).
The total infiltrated cell numbers in bronchoalveolar CBF1 mice (H-2Kb/d), the number of IL-17/ CD4 T
cells in the spleen of recipient CBF1 mice was similarlavage fluids (BALF) (Figure 6E) and the pulmonary pa-
thology (data not shown) were not different between the to that of IL-17/ CD4 T cells (Figure 7A). A similar
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Figure 7. Normal Acute GVHR by IL-17/
Donor Cells
Spleen cells from IL-17/ or IL-17/ mice
on the C57BL/6J background (H-2Kb/b) were
transferred into CBF1 (C57BL/6J x BALB/cA
F1: H-2Kb/d) mice intravenously.
(A) At indicated time points after the transfer,
the spleen of the recipient CBF1 mice was
removed, and the expansion of H-2KdCD4
or H-2KdCD8 cells of the donor IL-17/
or IL-17/ spleen cells and the reduction of
H-2KdB220 cells of the recipient CBF1 mice
were analyzed by FACS. Symbols represent
the average of three mice and SD.
(B) Proliferative responses of the recipient
CBF1 spleen cells to ConA at 10 days after
transfer. Each circle represents an individual
mouse, and average and SD are shown.
(C) CTL activity to P815 cells (H-2Kd). Ten
days after the transfer, H-2KdCD8 T cells
were purified from the recipient CBF1 spleen
cells by the MACS system. Specific lysis of
H-2KdP815 cells by H-2KdCD8 T cells was
determined by the 51Cr release assay. Sym-
bols represent the average of three mice
and SD.
tendency was also observed in CD8 T cells from IL- cells (Figure 7C). These results indicate that IL-17 defi-
ciency of donor T cells does not affect the development17/ mice (Figure 7A). The reduction kinetics of the
recipient B cells was also similar in mice that received of acute GVHR.
IL-17/ and IL-17/ T cells (Figure 7A). The ConA re-
sponse of the recipient spleen cells from CBF1 mice Discussion
that received IL-17/ and IL-17/ spleen cells was
similarly reduced (Figure 7B). No difference was ob- In the current study, we first generated IL-17/ mice
and demonstrated that IL-17 is involved in the develop-served between IL-17/ and IL-17/ CD8 T cells in
the cytotoxic T cell activity to H-2d-specific P815 target ment of various allergic diseases by activating allergen-
Figure 6. AHR in IL-17/ Mice
(A) OVA-specific T cell proliferative response. Mesenteric LN cells from IL-17/ or IL-17/ mice sensitized with OVA/alum intraperitoneally
were cultured in the absence or presence of 40 	g/ml OVA for 3 days. The average  SD of triplicate experiments is shown. These results
were reproducible in three independent experiments.
(B) IL-4, IL-5, and IFN- levels in pooled supernatant from three wells from proliferative response assay were determined by ELISA. These
results were reproducible in three independent experiments.
(C) OVA-specific antibody levels after AHR. Twenty-four hours after the last challenge with OVA, sera were collected, and OVA-specific Ig
levels were determined by ELISA. Each circle represents an individual mouse, and average and SD are shown.
(D) AHR to aerosolized methacholine in mice sensitized with OVA/alum intraperitoneally and challenged with OVA/PBS or PBS intranasally.
Airway bronchoconstriction was assessed by enhanced respiratory pause (Penh).
(E) Total cell numbers in BALF. At 24 hr after the last inhalation of OVA/PBS or PBS in mice sensitized with OVA/alum, the trachea was
cannulated and the airways were lavaged three times with 1 ml of PBS. The BALF was centrifuged, and cell numbers were counted manually.
(F) AHR in IL-17/ x DO11.10 Tg mice, who were treated with OVA/PBS or PBS intranasally without prior sensation to OVA. Airway bronchocon-
striction was assessed by Penh.
(G) Total cell numbers in BALF. At 24 hr after the last inhalation of OVA/PBS or PBS in IL-17/ or IL-17/ x DO11.10 Tg mice, BALF was
collected and cell numbers were counted manually as in (E). Each circle represents an individual mouse, and average and SD are shown.
(H) Lung histology in IL-17/ or IL-17/ x DO11.10 Tg mice inhaled with OVA/PBS. At 24 hr after the last inhalation, the lungs were removed
and sections of lung were stained with hematoxylin-eosin (60). Symbols represent the average of each genotype mice with SD in (D) and
(F). Each circle represents an individual mouse, and average and SD are shown in (C), (E), and (G). *, p 
 0.05.
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specific T cells. We have shown that the CHS response tory sites after challenge with TNCB (Figure 4B and our
unpublished data). Furthermore, we showed that TNF-was weak in IL-17/ mice, indicating involvement of IL-
17 in this response. was not necessary for the sensitization phase because
mice that received T cells from TNF-/ mice devel-Production of IL-17 is also reported in human skin-
derived nickel-specific T cells (Albanesi et al., 2000). The oped a normal CHS response (Nakae et al., submitted).
This finding is in clear contrast to the effect of IL-17CHS response is induced via multiple steps. At the initial
phase, LCs in the skin migrate into LNs upon stimulation deficiency, in which CHS response was significantly
suppressed in IL-17/ T cell-transplanted mice. Thesewith contact allergens; then, LCs maturate in LNs and
activate allergen-specific T cells through T-LC interac- observations indicate that IL-17 and TNF- play roles
in different processes. Consistent with this notion, wetion in the sensitization phase; and in the elicitation
phase, these allergen-primed T cells infiltrate into the found that CHS response in IL-17/ x TNF-/ mice
was significantly lower than in single cytokine knockoutskin and induce inflammation upon rechallenging with
the allergens (Grabbe and Schwarz, 1998). We showed mice as shown in Figure 4G.
AHR is a typical Th2-dependent immune reaction, andthat IL-17 deficiency affected neither migration (data not
shown) nor maturation of LCs (Figure 3D), although it IL-4, IL-5, and IL-13 are believed to be the key molecules
involved in the production of IgE and for the activationwas reported that exogenously added IL-17 promoted
maturation of DCs (Antonysamy et al., 1999). Instead, of mast cells and eosinophils (Lloyd et al., 2001). OVA/
alum-induced AHR developed normally in IL-17/ mice,we found that IL-17 is required for the activation of
hapten-specific CD4 but not CD8 T cells. Adoptive although IL-4 and IL-5 production by T cells and anti-
body production to OVA were reduced. In contrast, AHRtransfer experiments of TNCB-immunized T cells clearly
indicated that IL-17 is required for the sensitization induced by OVA/PBS inhalation was suppressed in IL-
17/ x DO11.10 Tg mice. The fact that alum can inducephase.
These observations suggest that the reduced CHS an excess Th2 response without IL-4R signaling
(Brewer et al., 1999) may be the cause of the differenceresponse in IL-17/ mice is caused by an insufficient
hapten-specific CD4 T cell activation in the sensitiza- seen between OVA/alum and OVA/PBS.
It is known that many asthmatic patients can develoption phase. With regard to this, it was shown previously
using MHC class I/ and MHC class II/ mice that the dramatic pathophysiological responses to challenge
with low doses of allergens (Sulakvelidze et al., 1998).effector cells in CHS response are CD8 T cells and
their activity is regulated by CD4 T cells (Bouloc et al., This indicates that AHR model induced by OVA/PBS,
rather than that by OVA/alum, seems to reflect more1998). Recently, however, it was shown using CD8/
and CD4/ mice that both CD8 and CD4 T cells are closely the pathology in humans. This notion is sup-
ported by the observation that B cell-deficient mice, asinvolved in the development of CHS, indicating that
CD4 T cells are necessary for full CD8 T cell activation well as mast cell-deficient mice, exhibited a normal AHR
when the animals were sensitized with OVA/alum (Kors-(Wong et al., 2000).
Proinflammatory cytokines such as IL-1 and TNF- gren et al., 1997; Takeda et al., 1997), although the gener-
ally accepted concept is that activation of mast cells byare known to have crucial roles in the induction of other
cytokines, chemokines, and adhesion molecules that the antigen/IgE complex is crucial for the development
of AHR (Martin et al., 1993). On the other hand, AHR inplay important roles in various inflammatory responses.
It has been suggested that IL-17 has activities similar mast cell-deficient mice sensitized with OVA without
alum was markedly suppressed (Williams and Galli,to these cytokines and is also known to be a potent
inducer of IL-1 and TNF- acting on macrophages and 2000). Moreover, we observed a similar phenomenon
when AHR was induced with OVA in IL-1// mice:kerationocytes (Albanesi et al., 1999, 2000; Jovanovic
et al., 1998). AHR was suppressed only when mice were immunized
with OVA/PBS but not with OVA/alum (our unpublishedAlthough the functional discrimination and synergy
among these cytokines are not completely known, there data). Although T cell functions such as proliferation
against OVA and cytokine production were suppressedare some indications that suggest a unique role for each
cytokine in the CHS reaction. In the elicitation phase, in IL-17/ mice sensitized with OVA/alum, these low
levels of T cell function seem to be enough to induceIL-1, IL-1, and TNF- were produced normally at the
inflammatory sites in IL-17/ mice both in terms of the full AHR. These findings indicate that IL-17 is not essen-
tial for the development of allergic airway hypersensitiv-induction kinetics and the protein levels, indicating that
the defect of the CHS reaction was directly caused by ity under strong AHR-inducing conditions using adju-
vant, but rather that IL-17 plays an important role underthe IL-17 deficiency and not by a deficiency of other
cytokines. conditions of mild inducement through activation of al-
lergen-specific T cells.We showed previously that IL-1 produced by APCs
is required for hapten-specific T cell activation in the DTH response is a Th1 cell-mediated cellular immune
response (Grabbe and Schwarz, 1998). We found thatsensitization phase and induces CD40L and OX40 on T
cells (Nakae et al., 2001a, 2001c). At present, we do not the DTH response was also impaired in IL-17/ mice
in the same way as in Th2-mediated AHR or Th1- andknow the molecular mechanisms for the activation of T
cells by IL-17. We only know that IL-17 production by Tc1-mediated CHS, and that IL-17 was required for aller-
gen-specific T cell activation in the sensitization phasehapten-specific T cells is reduced in IL-1// mice
(Nakae et al., submitted). We are now analyzing the during DTH, similarly to other responses. Thus, IL-17
seems to play an important role in activation of bothpossible mechanisms.
We found that, both IL-1 and TNF-, but not IL-17, Th1 and Th2 cells.
Host-versus-graft reaction (HVGR) is another T cell-were involved in vascular permeability at the inflamma-
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promoter was ligated to the 5 end of the targeting vector for nega-mediated immune response. Blockade of IL-17 binding
tive selection. The targeting vector was electroporated into ESwith IL-17R-Fc, an IL-17R extracellular domain fused
(E14.1) cells and selected in G418 (Asano et al., 1997). Targetedwith Fc fragment, caused prolonged allograft survival
clones were screened by Southern blot hybridization analysis using
(Antonysamy et al., 1999), which suggests the involve- 5 and 3 probes. Two clones out of seven independently identified
ment of IL-17 in HVGR. In GVHR, however, we showed targeted ES clones were treated with Adeno virus carrying the cre
gene to delete the neo gene (Kanegae et al., 1995). Chimera micethat IL-17 deficiency of donor T cells did not affect the
were generated by the aggregation method using C57BL/6J blasto-survival of recipient B cells and that alloantigen-specific
cysts as the recipients (Asano et al., 1997). Chimera mice wereCTL activity of IL-17/ CD8 T cells was normal. These
mated with C57BL/6J female mice for germline transmission. Forobservations indicate that donor CD4 T cell-produced
AHR, IL-17/ mice were backcrossed to BALB/cA mice for three
IL-17 is not required for allo-specific CD8 T cell activa- generations, and then crossed to DO11.10 transgenic mice, which
tion in acute GVHR. Consistent with this, it was reported were kindly provided by Dr. Dennis Y. Loh (Washington University
School of Medicine). For CHS and DTH, littermates of IL-17/ micethat expansion of allo-specific CD8 T cells occurred in
on 129 x B6 F1 background were used. The genotyping of IL-17/acute GVHR without the help of CD4 T cells, the major
mice was carried out using the following PCR primers: primer 1, 5-producer of IL-17 (Buhlmann et al., 1999).
ACTCTTCATCCACCTCACACGA-3; primer 2, 5-GCCATGATATAWe showed that antigen-specific antibody production
GACGTTGTGGC-3; primer 3, 5-CAGCATCAGAGACTAGAAGGGA-
was significantly decreased in IL-17/ mice. This effect 3. Primers 1 and 2 were used to detect wild-type allele (1.3 kb),
of IL-17 deficiency was not affected by the route of and primers 1 and 3 were used to detect mutant allele (0.5 kb). TNF-
/ mice were backcrossed to C57BL/6J mice for ten generationsimmunization or the presence of adjuvant. The suppres-
and used for the experiments.sion of antibody production was observed in the CHS
All the mice were kept under specific pathogen-free conditionsresponse, in which mice were sensitized with allergens
in an environmentally controlled clean room in the Laboratory Animalvia the skin route without adjuvants; in the DTH re-
Research Center, Institute of Medical Science, University of Tokyo.
sponse, in which mice were immunized intraperitoneally The experiments were conducted according to the institutional ethi-
with CFA; and in AHR, in which immunization was carried cal guidelines for animal experiments and the safety guidelines for
gene manipulation experiments.out intraperitoneally with alum. Since IL-17 deficiency
did not have any direct effects on B cells as assessed
Cell Proliferation Assayby the response against mitogenic stimuli such as LPS,
Cell preparation and mitogenic response were performed as de-anti-IgM mAb, and anti-CD40 mAb (data not shown),
scribed previously (Nakae et al., 2001a, 2001b). To measure thethese findings suggest that the observed defects on
mBSA- or OVA-specific LN cell response, LN cells (4  105 cells/
antibody production are due to insufficient B cell activa- well) were cultured in the absence or presence of 40 	g/ml of mBSA
tion by IL-17/ T cells. or OVA for 3 days, respectively, followed by incorporation of [3H]
Taken together, this study shows that IL-17 plays a thymidine (0.25 	Ci/ml) (Amersham, Buckinghamshire, England) for
6 hr. Data shown are from the time point of the maximal response.crucial role in allergen-specific cellular and humoral im-
mune responses through the activation of T cells, and
ELISA for Cytokines and Antigen-Specific Igswe have also provided insights into molecular mecha-
For cytokine ELISA, monoclonal rat anti-mouse IL-17 (DAKO, Car-nisms for the development of CHS, DTH and AHR. It
pinteria, CA), hamster anti-mouse IL-1mAb (Genzyme, Cambridge,
should be noted that IL-17 is specific because it medi- MA), hamster anti-mouse IL-1 mAb (Genzyme), and anti-mouse
ates both Th1-dominant allergic reactions such as CHS, TNF-mAb (ENDOGEN, Woburn, MA) as capture Abs and polyclonal
DTH, and collagen-induced arthritis (our unpublished biotinylated goat anti-mouse IL-17 antibody (DAKO), rabbit anti-
mouse IL-1 (Genzyme), rabbit anti-mouse IL-1 (Genzyme), anddata), and Th2-dominant reactions such as AHR. It is
rabbit anti-mouse TNF- (provided by Dr. Katsuo Noguchi, Teikyoreported that IL-17 is produced by a specific T cell sub-
University) as the second antibodies were used. HRP-avidin andpopulation that does not belong to Th1 or Th2 subpopu-
HRP-conjugated goat anti-rabbit IgG was purchased from Phar-
lations and produces TNF- and/or GM-CSF simultane- Mingen and Zymed (San Francisco, CA), respectively. TMB sub-
ously (Infante-Duarte et al., 2000). Thus, these strate was purchased from DAKO. ELISA for IL-4, IL-5, and IFN-
observations indicate that IL-17 belongs to a distinct was performed as previously described (Nakae et al., 2001b). TNP-,
mBSA-, and OVA-specific Ig levels were measured by ELISA ascategory of cytokine that belongs to neither Th1 nor
previously described (Nakae et al., 2001a, 2001c; Ohshima et al.,Th2 cytokines. These findings should be useful for the
1998).development of therapeutics for these diseases. Using
these IL-17/ mice, we are now examining the possibil-
CHSity that IL-17 is also involved in the development of other
TNCB-induced CHS, TNP-specific T cell proliferation, LC prepara-
T cell-mediated autoimmune diseases such as collagen- tion and maturation, and intracellular staining of FITCCD11c LCs
induced arthritis, inflammatory bowel disease, and ex- were assayed as described previously (Nakae et al., 2001c). In brief,
abdomen of mice were sensitized epicutaneously with TNCB; then,perimental autoimmune encephalomyelitis.
5 days later, the ear was challenged with 1% TNCB. At 24 hr after
the second challenge, mice were euthanized, and discs of ear tissueExperimental Procedures
were removed and weighed. Ear swelling was calculated as follows;
(Increment of ear swelling [mg]) {(weight of challenged ear [mg])Generation of IL-17/ Mice
Genomic DNA containing the il-17 gene was isolated from mouse (weight of vehicle-treated ear [mg])}. For FACS staining, PE-anti-
mouse CD40 mAb (3.23; Immunotech, Marseille Cedex, France), PE-129/SVJ genomic phage library (Stratagene, La Jolla, CA). A tar-
geting vector was constructed by replacing 2.1 kb genomic fragment anti-mouse CD86 mAb (RMMP-1; Immunotech), and PE anti-IL-12
p40/p70 (C15.6: kindly provided by Dr. T. Tamura) were used. Forwith the 2.5 kb DNA fragment containing the EGFP gene and neomy-
cin resistance gene (neo) under the control of the phosphoglycerate DC transfer, TNP-conjugated CD11c splenic DCs (5  105 cells)
were transferred into nontreated mice, and then DC-transferredkinase (PGK) 1 promoter which was flanked by lox P sequences.
The fragment contained the first and second exons, which ranged mice were challenged with TNCB. DNFB-induced CHS, DNP-spe-
cific T cell response, and adoptive T cell transfer were performedfrom the initiation codon ATG to a SnaBI site between the second
and third exons. A diphtheria toxin A (DT) gene under the MC1 according to Chen et al. (1999). For reconstitution assay, CD4 T
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